HomeCompareANGN vs SPHD

ANGN vs SPHD: Dividend Comparison 2026

ANGN yields 200.00% · SPHD yields 4.33%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ANGN wins by $119.34M in total portfolio value
10 years
ANGN
ANGN
● Live price
200.00%
Share price
$1.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$119.36M
Annual income
$60,176,096.29
Full ANGN calculator →
SPHD
SPHD
● Live price
4.33%
Share price
$49.34
Annual div
$2.14
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$571.32
Full SPHD calculator →

Portfolio growth — ANGN vs SPHD

📍 ANGN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodANGNSPHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ANGN + SPHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ANGN pays
SPHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ANGN
Annual income on $10K today (after 15% tax)
$17,000.00/yr
After 10yr DRIP, annual income (after tax)
$51,149,681.85/yr
SPHD
Annual income on $10K today (after 15% tax)
$367.92/yr
After 10yr DRIP, annual income (after tax)
$485.62/yr
At 15% tax rate, ANGN beats the other by $51,149,196.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ANGN + SPHD for your $10,000?

ANGN: 50%SPHD: 50%
100% SPHD50/50100% ANGN
Portfolio after 10yr
$59.70M
Annual income
$30,088,333.80/yr
Blended yield
50.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ANGN right now

ANGN
Analyst Ratings
1
Buy
3
Hold
Consensus: Hold
Price Target
$1.50
+50.0% upside vs current
Range: $1.50 — $1.50
Altman Z
-16.3
Piotroski
3/9
SPHD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ANGN buys
0
SPHD buys
0
No recent congressional trades found for ANGN or SPHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricANGNSPHD
Forward yield200.00%4.33%
Annual dividend / share$2.00$2.14
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$119.36M$26.5K
Annual income after 10y$60,176,096.29$571.32
Total dividends collected$112.49M$5.1K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: ANGN vs SPHD ($10,000, DRIP)

YearANGN PortfolioANGN Income/yrSPHD PortfolioSPHD Income/yrGap
1← crossover$30,700$20,000.00$11,133$432.85+$19.6KANGN
2$90,232$57,383.18$12,363$450.36+$77.9KANGN
3$254,173$157,624.56$13,695$467.39+$240.5KANGN
4$686,927$414,961.74$15,138$483.90+$671.8KANGN
5$1,783,118$1,048,106.39$16,697$499.88+$1.77MANGN
6$4,450,613$2,542,677.12$18,382$515.31+$4.43MANGN
7$10,693,420$5,931,263.38$20,198$530.17+$10.67MANGN
8$24,760,608$13,318,648.86$22,157$544.46+$24.74MANGN
9$55,315,649$28,821,798.66$24,266$558.18+$55.29MANGN
10$119,363,841$60,176,096.29$26,536$571.32+$119.34MANGN

ANGN vs SPHD: Complete Analysis 2026

ANGNStock

Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primarily in the kidney and lung. It also develops ANG-3777, a hepatocyte growth factor mimetic to treat acute organ injuries, such as delayed graft function; ROCK2 inhibitors programs for fibrotic diseases; and CYP11B2 inhibitor program. The company was incorporated in 1998 and is based in Uniondale, New York.

Full ANGN Calculator →

SPHDETF

The Invesco S&P 500 High Dividend Low Volatility ETF (Fund) is based on the S&P 500 Low Volatility High Dividend Index (Index). The Fund will invest at least 90% of its total assets in common stocks that comprise the Index. Standard & Poor's compiles, maintains and calculates the Index, which is composed of 50 securities traded on the S&P 500 Index that historically have provided high dividend yields and low volatility. The Fund and the Index are rebalanced and reconstituted semi-annually, in January and July.

Full SPHD Calculator →
📬

Get this ANGN vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ANGN vs SCHDANGN vs JEPIANGN vs OANGN vs KOANGN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.